• LinkedIn
  • Twitter

Harness AI to Boldly Develop and Deliver Revolutionary Therapies for Patients with Serious Diseases.

Big data and artificial intelligence concept. Machine learning and circuit board. Deep lea

METiS Therapeutics is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.

The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism-driven quantum mechanics and molecular dynamics simulations to calculate active pharmaceutical ingredient (API) properties, elucidate API-target and API-excipient interactions, and predict chemical, physical and pharmacokinetic properties of small molecule and nucleic acid therapeutics in specific microenvironments. This enables efficient lead optimization, candidate selection and formulation design.

 

Our Mission

Build a world-class proprietary predictive AI platform to redefine drug discovery

Create a robust and targeted delivery system for small molecules, RNA and gene therapies

Provide clinical value to patients by exploring the uncharted territory of AI and the new biology

Artificial intelligence (AI), data mining, deep learning modern computer technologies. _Fu

Partnering

METiS is interested on in-licensing novel assets with high therapeutic potential that could benefit from our technologies. To inquire about partnering with METiS or to collaborate on an external program, please reach out to partner@metistx.com.

We take pride in our investors

5Y.png
ChinaLifePrivateEquityInvestmentCompanyLimited.png
Lighetspeed.jpg
Free Fund.png
SOURCE CODE CAPITAL.png
CMBI logo_20211129110407 (003).jpeg
XtaIp.png

Behind Our Groundbreaking Technologies and Drug Discovery Efforts is a Talented Team.